Sign inJoin waitlistJoin the waitlist

Kenneth Sherman

Division Chief · University of Cincinnati Medical Center Inc.

Credentials: · · · · · ·

History

University of Cincinnati Medical Center Inc.
Present
University of Cincinnati Medical Center Inc.
Present

Tripler Army Medical Center
1987–1990
Fitzsimons Army Medical Center
1986–1987
Internal Medicine
Tripler Army Medical Center
1985–1986
George Washington Univ Sch of Med
1981–1985
Rutgers University (Microbiology

Research

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
New England Journal of Medicine · 2004 · 720 citations
Response-guided telaprevir combination treatment for hepatitis C virus infection
New England Journal of Medicine · 2011 · First of 17 authors · Corresponding · 613 citations
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group
Clinical Infectious Diseases · 2002 · First of 4 authors · Corresponding · 577 citations

Raymond Chung
26 papers
Adeel Butt
22 papers
Marion Peters
15 papers
MK
Margaret Koziel
12 papers
MS
Mark Sulkowski
10 papers
ZG
Zachary Goodman
10 papers
Kristen Marks
8 papers
David Nelson
7 papers
Mark Eckman
7 papers
Michael Fried
7 papers
Nadeem Anwar
7 papers
Obaid Shaikh
7 papers

Grants

Biomarkers of Replication and Injury in HBV/HIV
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $444K · University of Cincinnati
2021–2024
HIV and Liver Disease Conference
National Institute of Allergy and Infectious Diseases · R13
Contact PI · $306.9K · University of Cincinnati
2006–2024
Hepatitis E in HIV-Infected Patients
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.4M · University of Cincinnati
2015–2021
HIV Antiretroviral Therapy and Hepatic Injury
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $5.5M · University of Cincinnati
2006–2021

Clinical trials

Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Principal investigator · Completed · Phase 1
Kenneth Sherman
2012–2014
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Principal investigator · Completed · Phase 3
Vertex Pharmaceuticals Incorporated
2008–2010
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
Principal investigator · Completed · Phase 1
University of Cincinnati
2006–2012
Treatment of Hepatitis C in Hemophilic Patients With HIV
Principal investigator · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2002–2005